Peter T Miller

US Patent:

7504118, Mar 17, 2009

Filed:

Apr 12, 2004

Appl. No.:

10/823429

Inventors:

Peter Miller - Broomfield CO, US
Timothy Romero - Sarasota FL, US

Assignee:

FHG Corporation - Spring Hill TN

International Classification:

A61K 36/05
A61K 31/195

US Classification:

424739, 514554, 514565

Abstract:

Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.

US Patent:

8003141, Aug 23, 2011

Filed:

Mar 16, 2009

Appl. No.:

12/404930

Inventors:

Peter Miller - Broomfield CO, US
Timothy Romero - Columbia TN, US

Assignee:

Integrity Nutraceuticals - Spring Hill TN

International Classification:

A61K 36/05
A61K 36/195

US Classification:

424739, 514554, 514565

Abstract:

Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.

US Patent:

8318221, Nov 27, 2012

Filed:

Jul 21, 2011

Appl. No.:

13/187771

Inventors:

Peter J. Miller - Broomfield CO, US
Timothy Romero - Sarasota FL, US

Assignee:

FHG Corporation - Spring Hill TN

International Classification:

A61K 36/05
A61K 36/195

US Classification:

424739, 514554

Abstract:

Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.

US Patent:

20130072574, Mar 21, 2013

Filed:

May 26, 2011

Appl. No.:

13/699779

Inventors:

Peter J. Miller - Broomfield CO, US
Tim Romero - Sarasota FL, US
Bolin Qin - Gaithersburg MD, US
Augustin T. Romero - Spring Hill TN, US

Assignee:

FHG CORPORATION D/B/A INTEGRITY NUTRACEUTICALS - Spring Hill TN

International Classification:

A61K 38/06
A61K 36/54
A61K 31/05
A61K 31/08

US Classification:

514736

Abstract:

A dietary supplement composition is provided for enhancing the expression of a sirtuin gene or protein. An inventive supplement composition includes at least one cinnamon extract containing at least 0.5% doubly linked Type-A polymers by dry weight. The cinnamon extract is derived from the or plant. In some embodiments, the cinnamon extract is present at approximately 20%-50% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is optionally provided in the composition. The dietary supplement composition is administered orally to promote expression or enhanced expression of a sirtuin gene or protein.

US Patent:

20150140135, May 21, 2015

Filed:

Jan 30, 2015

Appl. No.:

14/610311

Inventors:

Peter J. Miller - Broomfield CO, US
Timothy Romero - Columbia TN, US

Assignee:

IN Ingredients, Inc. - Columbia TN

International Classification:

A61K 36/54
A61K 36/74
A23L 1/30
A61K 31/685
A61K 36/24
A61K 31/522
A61K 36/82
A61K 36/575

US Classification:

424729, 424739

Abstract:

A method for promoting weight loss and/or lowering blood glucose comprises an active material which may be cinnamon, an extract of cinnamon, or a derivative of a cinnamon extract. The active material may be utilized in combination with further active ingredients.